Terms: = Sarcomas AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790
14 results:
1. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
[TBL] [Abstract] [Full Text] [Related]
2. Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
[TBL] [Abstract] [Full Text] [Related]
3. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
[TBL] [Abstract] [Full Text] [Related]
4. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract] [Full Text] [Related]
5. Angioimmunoblastic T-Cell Lymphoma with Exuberant CD30-Positive Follicular Dendritic Cell Proliferation in a SARS-CoV-2 Patient: The Role of Mutational Analysis to Exclude an Associated Follicular Dendritic Cell Sarcoma.
Rogges E; Pelliccia S; Lopez G; Barresi S; Tafuri A; Alaggio R; Di Napoli A
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012614
[TBL] [Abstract] [Full Text] [Related]
6. Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma.
Zhao H; Dong Z; Wan D; Cao W; Xing H; Liu Z; Fan J; Wang H; Lu R; Zhang Y; Cheng Q; Jiang Z; He F; Xie X; Guo R
Sci Rep; 2022 Apr; 12(1):6752. PubMed ID: 35474239
[TBL] [Abstract] [Full Text] [Related]
7. A Pedigree Analysis and Clonal Correlations of the Coexistence of B-Cell Lymphoma and Histiocytic/Dendritic Cell Tumor.
Cheng F; Yu F; Wang X; Huang K; Lu H; Wang Z
Int J Surg Pathol; 2021 Dec; 29(8):906-914. PubMed ID: 33939500
[TBL] [Abstract] [Full Text] [Related]
8. Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.
Akin DF; Oner DA; Kurekci E; Akar N
Bratisl Lek Listy; 2018; 119(6):366-372. PubMed ID: 29947237
[TBL] [Abstract] [Full Text] [Related]
9. tet2-dependent IL-6 induction mediated by the tumor microenvironment promotes tumor metastasis in osteosarcoma.
Itoh H; Kadomatsu T; Tanoue H; Yugami M; Miyata K; Endo M; Morinaga J; Kobayashi E; Miyamoto T; Kurahashi R; Terada K; Mizuta H; Oike Y
Oncogene; 2018 May; 37(22):2903-2920. PubMed ID: 29515232
[TBL] [Abstract] [Full Text] [Related]
10. Decrease of tet2 expression and increase of 5-hmC levels in myeloid sarcomas.
Xiao D; Shi Y; Fu C; Jia J; Pan Y; Jiang Y; Chen L; Liu S; Zhou W; Zhou J; Tao Y
Leuk Res; 2016 Mar; 42():75-9. PubMed ID: 26811000
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of PET/CT in multifocal myeloid sarcomas with loss of tet2: a case report and literature review.
Pan Y; Tao Y; Fu C; Jia J; Liu S; Xiao D
Int J Clin Exp Pathol; 2015; 8(10):13630-4. PubMed ID: 26722587
[TBL] [Abstract] [Full Text] [Related]
12. Mutational Hotspot of tet2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.
Zorzan E; Hanssens K; Giantin M; Dacasto M; Dubreuil P
PLoS One; 2015; 10(11):e0142450. PubMed ID: 26562302
[TBL] [Abstract] [Full Text] [Related]
13. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for tet2.
Guilhamon P; Eskandarpour M; Halai D; Wilson GA; Feber A; Teschendorff AE; Gomez V; Hergovich A; Tirabosco R; Fernanda Amary M; Baumhoer D; Jundt G; Ross MT; Flanagan AM; Beck S
Nat Commun; 2013; 4():2166. PubMed ID: 23863747
[TBL] [Abstract] [Full Text] [Related]
14. Mutations of the epigenetics-modifying gene (DNMT3a, tet2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia.
Wakita S; Yamaguchi H; Omori I; Terada K; Ueda T; Manabe E; Kurosawa S; Iida S; Ibaraki T; Sato Y; Todoroki T; Hirakawa T; Ryotokuji T; Arai K; Kitano T; Mitamura Y; Kosaka F; Dan K; Inokuchi K
Leukemia; 2013 Apr; 27(5):1044-52. PubMed ID: 23135354
[TBL] [Abstract] [Full Text] [Related]
